UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cutter & CO Brokerage Inc.

Cutter & CO Brokerage Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,203 shares of the healthcare conglomerate’s stock after selling 73 shares during the quarter. Cutter & CO Brokerage Inc.’s holdings in UnitedHealth Group were worth $633,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. GAMMA Investing LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $2,441,000. Eudaimonia Advisors LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the 4th quarter. Eudaimonia Advisors LLC now owns 1,583 shares of the healthcare conglomerate’s stock valued at $833,000 after buying an additional 25 shares during the last quarter. Linden Thomas Advisory Services LLC raised its position in UnitedHealth Group by 25.9% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 2,219 shares of the healthcare conglomerate’s stock valued at $1,168,000 after acquiring an additional 456 shares in the last quarter. Community Bank & Trust Waco Texas raised its holdings in shares of UnitedHealth Group by 3.6% during the 4th quarter. Community Bank & Trust Waco Texas now owns 12,368 shares of the healthcare conglomerate’s stock valued at $6,511,000 after purchasing an additional 434 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 100.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 5,378 shares of the healthcare conglomerate’s stock worth $2,831,000 after acquiring an additional 2,693 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Bank of America restated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Down 1.0 %

UNH traded down $4.86 on Tuesday, hitting $486.37. 3,645,655 shares of the company were exchanged, compared to its average volume of 4,543,351. The company has a market cap of $448.40 billion, a PE ratio of 29.72, a PEG ratio of 1.38 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock’s fifty day moving average is $488.10 and its 200-day moving average is $515.03. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the business earned $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.